The Hudson Institute is pleased announce the appointment of distinguished scientist Professor Warwick Anderson AM to its board of governance.
Professor Anderson led the NHMRC, Australia’s major governmental funding body for health and medical research, for almost nine years until March this year.
He is also the former Head of Monash University’s School of Biomedical Sciences and former Deputy Director of the Baker Medical Research Institute.
Hudson Director, Professor Bryan Williams, says the Institute is privileged to welcome a board member of Professor Anderson’s calibre.
“Professor Anderson brings varied experience as a medical researcher, and at the helm of Australia’s foremost funding body,” Professor Williams said.
“His knowledge will be invaluable as we work to galvanise our research strengths, particularly in Australia’s shifting medical research funding landscape.”
Professor Anderson completed research fellowships at the University of Sydney and Harvard Medical School.
His research has focused on renal causes of hypertension, including the roles of renal vascular remodeling, renal innervation and the renin-angiotensin system.
He has a history of serving on medical and scientific boards and committees, and currently serves on the International Advisory Committee on Biomedical Science for Singapore and the Dana-Farber Cancer Institute’s Presidential Visiting Committee.
“The Hudson Institute has a long and celebrated history in medical research and discovery, fusing the legacies of the Monash Institute of Medical Research and the Prince Henry’s Institute,” Professor Anderson said.
“With partners Monash Health and Monash University, and an exciting new strategic direction, the newly merged Hudson Institute is set to turn Melbourne’s populated Southeastern corridor into its health and research hub.
“I look forward to playing a role in these transformative years for the Hudson Institute and eagerly await the real and lasting impact the Institute will make on human health.”
Professor Anderson is an Honorary Fellow of the Royal College of Pathologists of Australasia and an International Fellow of the Council for High Blood Pressure of the American Heart Foundation.